Centessa Pharmaceuticals plc CNTA

Latest FY: 2025 Healthcare Biotechnology
Market Price $40.55
Market Cap $6.27B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025)
$15.00M
Full year reported
Net Income ↑16.2% YoY
-$197.53M
Net Margin: -1,316.9%
Free Cash Flow ↓-36.7% YoY
-$194.19M
FCF Yield: -3.10%
EPS (Diluted) ↑29.1% YoY
$-1.46
Basic: $-1.46
Return on Equity Efficiency
-37.5%
ROA: -28.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (CNTA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2020 $-10.7M $-10.6M $-10.6M
FY 2021 $-381.1M -3,473.8% $-5.07 $-135.1M $-135.3M -1,172.8%
FY 2022 $-216.2M +43.3% $-2.31 +54.4% $-200.5M $-201.7M -49.1%
FY 2023 $6.9M $6.9M $-151.1M +30.1% $-1.57 +32.0% $-160.3M $-160.5M +20.4%
FY 2024 -100.0% $-235.8M -56.0% $-2.06 -31.2% $-142.1M $-142.1M +11.5%
FY 2025 $15.0M $3.5M $-197.5M +16.2% $-1.46 +29.1% $-193.8M $-194.2M -36.7%
$

Valuation

Market Price $40.55
Market Cap $6.27B
Enterprise Value $6.32B
P/E Ratio N/A
P/B Ratio 11.91
FCF Yield -3.10%
Dividend Yield 0.00%
Shares Outstanding 154,728,966
%

Profitability & Margins

Gross Margin 23.61%
Operating Margin -1,384.61%
Net Margin -1,316.88%
Return on Equity (ROE) -37.49%
Return on Assets (ROA) -28.73%
Asset Turnover 0.02x
Revenue 3-Yr CAGR N/A
🛡️

Financial Health & Liquidity

Current Ratio 8.57
Cash Ratio 1.43
Debt / Equity 0.225
Debt / Assets 0.172
Cash & Equivalents $61.30M
Total Debt $118.38M
Book Value / Share $3.41
💧

Cash Flow Efficiency

Operating Cash Flow -$193.82M
Capital Expenditures (CapEx) $371.00K
Free Cash Flow -$194.19M
OCF / Revenue -1,292.11%
FCF / Revenue -1,294.59%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.46
EPS (Basic) $-1.46
Dividends / Share N/A
Book Value / Share $3.41
EPS YoY Growth 29.13%
🏛️

Balance Sheet (FY 2025)

Total Assets $687.50M
Total Liabilities $160.63M
Stockholders' Equity $526.86M
Current Assets $367.88M
Current Liabilities $42.94M